International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 1 : 2515-2521
Research Article
Clinical Profile, Laboratory Markers Predicting Severity and Outcomes of Acute Lower Respiratory Tract Infections in Under-Five Children in South India
 ,
 ,
 ,
Received
Jan. 15, 2026
Accepted
Feb. 16, 2026
Published
Feb. 22, 2026
Abstract

Introduction: Acute lower respiratory tract infection (ALRI) remains a leading cause of morbidity and mortality among under-five children, particularly in India. Early identification of severe cases is critical for timely intervention, especially in resource-limited settings. This study aimed to evaluate the clinical profile and laboratory markers predicting severity and immediate outcomes of ALRI in under-five children in South India.

Methods: This prospective observational study was conducted from January 2014 to June 2015 at a tertiary care teaching hospital in South India. One hundred children aged 1 month to 5 years admitted with ALRI, defined according to WHO criteria, were enrolled. Children with chronic respiratory or cardiac illnesses were excluded. Detailed clinical evaluation and laboratory investigations, including total leukocyte count (TLC), blood culture, and chest radiography, were performed. ALRI cases were categorized into pneumonia and severe pneumonia based on WHO severity criteria. Outcomes assessed at discharge included need for oxygen supplementation, mechanical ventilation, improvement, or death. Statistical analysis was performed using the Chi-square test, with p < 0.05 considered significant.

Results: Among 100 children, 78% were classified as pneumonia and 22% as severe pneumonia. The most common presenting features were breathlessness (97%), cough (93%), fever (90%), and chest indrawing (86%). Bronchopneumonia (48%) was the most frequent diagnosis, followed by bronchiolitis (33%) and lobar pneumonia (8%). Leukocytosis was observed in 28% of cases and was significantly associated with severe pneumonia (p < 0.001). Blood culture positivity was 6% and showed significant association with disease severity (p = 0.001). Oxygen supplementation was required in 92% of cases, mechanical ventilation in 9%, and overall mortality was 3%, occurring exclusively among severe pneumonia cases.

Conclusion: Clinical features such as breathlessness, fever, cough, and chest indrawing remain key indicators of ALRI severity. Leukocytosis and positive blood culture, though less frequent, are significant predictors of severe disease. Early clinical assessment supported by selective laboratory evaluation can aid risk stratification and improve outcomes in under-five children with ALRI

Keywords
INTRODUCTION

Acute Lower Respiratory Tract Infection (ALRI) is the leading cause of under-five childhood morbidity in the world, with nearly 156 million new episodes each year, of which India accounts for a bulk of 43 million. The mortality burden is 1.9 million per year, out of which India accounts for around 400,000 deaths per year [1].

 

According to Child Health Epidemiology Reference Group (CHERG) latest estimates for 2010, pneumonia was responsible for 0.397 million of total estimated 1.682 million under-5 deaths in India [2].

 

In India, pneumonia was responsible for about 18% of all under five deaths [3]. In Andhra Pradesh alone, 55,308 children were affected by pneumonia and 29,137 were males and 26,171 were females; and among them, 189 died of pneumonia,of which 107 were males and 82 were females [3].

 

Distribution of Under five deaths [4] ;

Globally

10.6 million

SEAR

3.1      million

INDIA

0.24 million

 

Need for the Study

Acute lower respiratory tract infection (ALRI) remains a leading cause of morbidity and mortality in under five children, particularly in India, where the burden accounts for a large proportion of global cases and deaths. Despite improvements in healthcare, early identification of children at risk of severe disease is challenging, especially in resource-limited settings in India. Understanding the clinical features and laboratory markers that predict severity and outcomes can help clinicians prioritize care, guide treatment, and improve survival. This study aims to provide evidence from South India on which clinical signs are common and which laboratory markers are most predictive of severe ALRI, thereby aiding early risk stratification and better management of under-five children with ALRI.

 

Aims and Objectives

Aim

To evaluate the common clinical profiles and laboratory markers that predict the severity and outcomes of acute lower respiratory tract infection (ALRI) at discharge in under five children in South India.

 

Objectives

  1. To document the clinical profile, including presenting symptoms and signs of children with ALRI
  2. To evaluate laboratory markers such as total leukocyte count and blood culture in relation to severe ALRI
  3. To categorize ALRI cases into clinical diagnoses such as bronchopneumonia, bronchiolitis, lobar pneumonia, WALRI, croup, and empyema thoracis
  4. To determine the immediate outcomes at discharge of ALRI.

 

MATERIALS AND METHODS

The study was a prospective observational study conducted at Alluri Sitarama Raju Academy of Medical Sciences College, Eluru, West godavari district, Andhra Pradesh, India from January 2014 to June 2015. Children aged 1 month to 5 years admitted with a clinical diagnosis of Acute lower respiratory tract infection (ALRI) according to WHO criteria were enrolled, while those with chronic respiratory or cardiac illnesses were excluded. ALRI was defined as cough with fast breathing (≥60/min for <2 months, ≥50/min for 2–12 months, ≥40/min for 12–60 months), with or without chest indrawing, and illness duration of less than 30 days. Severe pneumonia was defined by the presence of refusal of feeds, lethargy, central cyanosis, or convulsions. After obtaining informed consent from caregivers, a detailed history and physical examination were conducted using a predesigned proforma, which included demographics, anthropometry, presenting symptoms such as fever, cough, breathlessness, chest indrawing, wheeze, refusal of feeds, lethargy, vomiting/diarrhea, and convulsions, immunization and breastfeeding history, dietary intake, recent upper respiratory infections in family members, environmental exposures such as household smoking, cooking fuel, and housing conditions, socioeconomic status based on the modified Kuppuswamy classification, and malnutrition assessment according to Indian Academy of Pediatrics criteria.

Investigations included complete blood count, chest X-ray, and other tests as clinically indicated. Blood culture performed in all cases to identify bacterial pathogens. All cases were managed according to standard hospital protocols, including oxygen supplementation, respiratory supportive therapy in the form of mechanical ventilation when required. Immediate outcomes at discharge, including improvement and discharge, need for oxygen support or mechanical ventilation, or death, were recorded.

Statistical Analysis:

Data were tabulated and analyzed using appropriate statistical methods. Chi-square test was used to assess associations between clinical/laboratory variables and disease severity. A p-value <0.05 was considered statistically significant.

 

RESULTS

The present study was conducted on 100 children aged 1 month to 5 years with Acute lower respiratory tract infection to evaluate presenting complaints and laboratory markers like TLC, Blood culture and immediate outcome at discharge.

Distribution of Presenting complaints:

The various presenting complaints among the 100 cases of ALRI were as follows

Table 1

Breathlessness

97 (97%)

Cough

93 (93%)

Fever

90 (90%)

Chest indrawing

86 (86%)

Rhinorrhea

59 (59%)

Refusal of feeds

27 (27%)

Wheeze

10 (10%)

Lethargy/ Unconsciousness

6  (6%)

Persistent vomiting/ Diarrhoea

5  (5%)

Convulsions

3  (3%)

 

Figure 1 : Distribution of  Presenting complaints

Presenting complaints

120

100

80

60

40

20

0

Presenting complaints

 

Table 2: Total Leukocyte Count

Occurrence of leukocytosis was 28% among the 100 ALRI cases, and significant association (p<0.001) was found between leukocytosis and ALRI severity.

 

Total leucocyte count

ALRI

Total leucocyte count

Severe pneumonia

 

Normal

4 (18.1%)

 

Normal

72 (72%)

 

Raised

28 (28%)

Raised

18 (81.9%)

 

Total

100 (100%)

Total

22 (100%)

 

ALRI : Acute lower respiratory tract infection

Chi2 =40.52          DF=1     p<0.001*

Figure 2 Total leukocyte count

100%

90%

80%

70%

60%

50%

40%

30%

20%

10%

0%

Severe pneumonia

Total leukocyte count

Normal

Raised

 

Table 3 : Blood Culture

Among the 100 ALRI cases, only 6% had a positive blood culture. However,

significant association (p= 0.001*) was found between ALRI severity and blood culture

Blood culture

ALRI

Blood culture

Severe pneumonia

Positive

6 (6%)

Positive

5 (22.7%)

Negative

94 (94%)

Negative

17 (77.3%)

Total

100 (100%)

Total

22 (100%)

ALRI : Acute lower respiratory tract infection

Chi2 (Yates) =10.499         DF=1     p=0.001*

 

100%

90%

80%

70%

60%

50%

40%

30%

20%

10%

0%

Severe pneumonia

Blood culture

Positive                                   Negative

Figure 3 : Blood culture

 

 

Table 4: Final Diagnosis

The most common diagnosis was bronchopneumonia (48%), and the other major diagnoses were bronchiolitis and lobar pneumonia 33% and 8% respectively. WALRI accounted for 5%, Croup (acute laryngo tracheo bronchitis) for 4% of cases, empyema thoracis accounted for 2 %.

 

Final diagnosis

Number

Bronchopneumonia

48 (48%)

Bronchiolitis

33 (33%)

Lobar pneumonia

8  (8%)

WALRI

5  (5%)

Croup/ALTB

4  (4%)

Empyema thoracis

2  (2%)

Total

100 (100%)

 

Figure 4 Final diagnosis

Final Diagnosis

5%

4% 2%

8%

Bronchopneumonia

48%

33%

Bronchiolitis

Lobar Pneumonia WALRI

Croup/ALTB

Empyema

 

Table 5 :  Outcome

Among the 100 ALRI cases, 92% required oxygen supplementation at any time during the hospital stay and 9% required mechanical ventilation. 3 cases died, and 97 cases improved and discharged.

 

Cases

Oxygen supplementation

Ventilation

Improved

Death

Pneumonia

78(78%)

70

0

78

0

Severe pneumonia

22(22%)

22

9

19

3

Total

100(100%)

92 (92%)

9 (9%)

97

3

 

Diagnosis

Number

Pneumonia

Severe pneumonia

O2

required

Mechanical ventilation

Improved

Death

Broncho

pneumonia

48

36

12

45

6

46

2

Bronchiolitis

33

25

8

29

2

33

0

Lobar

pneumonia

8

6

2

8

1

7

1

WALRI

5

5

0

4

0

5

0

ALTB/Croup

4

4

0

4

0

4

0

Empyema

thoracis

2

2

0

2

0

2

0

Total

100

78

22

92

09

97

3

 

DISCUSSION

Acute lower respiratory tract infections (ALRI) remain a leading cause of morbidity and mortality in children under five, particularly in low- and middle-income countries like India. In the present study of 100 children aged 1 month to 5 years, the most common presenting complaints were breathlessness (97%), cough (93%), fever (90%), and chest indrawing (86%), consistent with previous studies. Amitoj et al. [5] reported similar findings, with fever, cough, and breathlessness present in 90–100% of cases, highlighting that these symptoms remain reliable clinical indicators of ALRI severity.

 

Regarding severity grading, 78% of cases were classified as pneumonia and 22% as severe pneumonia. This is comparable to the study by Yousif et al.[6], which reported 48% pneumonia and 28% severe/very severe pneumonia, and to Savitha et al.[7], although variations exist due to differences in classification criteria and population demographics.

 

The final diagnosis in this study revealed bronchopneumonia (48%) as the most common entity, followed by bronchiolitis (33%) and lobar pneumonia (8%). These findings are similar to Amitoj et al.[5], though their study reported bronchiolitis as the leading diagnosis, reflecting regional or seasonal variations in pathogen prevalence.

 

In terms of laboratory parameters, leukocytosis was observed in 28% of cases and showed a significant association with severe pneumonia (p=0.000). This aligns with Amitoj et al.[5], who reported leukocytosis in 22% of cases with a similar correlation to severity, confirming that elevated total leukocyte count, while not universal, can aid in risk stratification. Blood culture positivity was low (6%) but significantly associated with severe pneumonia (p=0.001), with Streptococcus pneumoniae being the most common organism. Previous studies reported similar low positivity rates, ranging from 8% in Amitoj et al.[5] to 17% in Delport et al.[8], reflecting the limitations of blood culture sensitivity in pediatric ALRI.

 

Management and outcomes showed that 92% of children required oxygen supplementation, while 9% required mechanical ventilation, all among severe cases. Mortality was observed in 3 cases, yielding a mortality rate of 13.6% among severe pneumonia cases, comparable to reports by Banajeh et al.[9] (9.8%) and Nantanda et al.[10] (15.3%). These outcomes emphasize that timely recognition and supportive care significantly improve survival, though severe cases remain at high risk.

 

This study reinforces that clinical assessment remains the most practical and reliable tool for early identification of severe ALRI in under five children. Laboratory markers, though less frequent, provide additional prognostic value. The findings highlight the importance of combining thorough clinical evaluation with targeted laboratory investigations to guide timely intervention, especially in resource-limited settings like South India.

 

CONCLUSION

In this study of 100 children under five with ALRI, clinical signs such as breathlessness, fever, cough, and chest indrawing were present in most cases. Laboratory markers, including leukocytosis and positive blood culture, were less frequent but significantly associated with severity of ALRI. Oxygen supplementation and mechanical ventilation were required in severe cases, and mortality was observed among these cases. Careful assessment of clinical features remains the most practical and reliable tool for early identification of severe pneumonia, while laboratory tests can provide additional prognostic information in selected cases. Early recognition and timely intervention based on these indicators can improve outcomes in under-five children with acute lower respiratory tract infection in South India.

 

Limitations: This study was conducted at a single center with a relatively small sample size, which may limit the generalizability of the findings. Only immediate outcomes at discharge were assessed, and long-term morbidity or recurrence was not evaluated.

REFERENCES

  1. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86:408–416. doi:10.2471/BLT.07.048769
  2. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–2161. doi:10.1016/S0140-6736(12)60560-1
  3. National Health Profile 2011. New Delhi: Government of India, Directorate General of Health Services, Ministry of Health and Family Welfare; 2011.
  4. World Health Organization. Regional Office for South-East Asia. Health situation in the South-East Asia Region 2001–2007. New Delhi: WHO Regional Office for South-East Asia; 2009.
  5. Chhina AS, Iyer CR, Gornale VK, Katwe N, S S, P J H, C K C. Clinical profile of acute lower respiratory tract infections in children between 2 months and 5 years. J Evid Based Med Healthc. 2015;2(35):5426–5431. doi:10.18410/jebmh/2015/754
  6. Yousif TK, Khaleq BANA. Epidemiology of acute lower respiratory tract infections among children under five years attending Tikrit General Teaching Hospital. Middle East J Fam Med. 2006;4(3):48–51.
  7. Savitha MR, Nandeeshwara SB, Pradeep Kumar MJ, Ul-Haque F, Raju CK. Modifiable risk factors for acute lower respiratory tract infections. Indian J Pediatr. 2007;74:477–482. doi:10.1007/s12098-007-0113-8
  8. Delport SD, Brisley T. Aetiology and outcome of severe community-acquired pneumonia in children admitted to a paediatric intensive care unit. S Afr Med J. 2002 Nov;92(11):907–911.
  9. Banajeh SM. Outcome for children under 5 years hospitalized with severe acute lower respiratory tract infections in Yemen: a 5-year experience. J Trop Pediatr. 1998 Dec;44(6):343–346. doi:10.1093/tropej/44.6.343
  10. Nantanda R, Hildenwall H, Peterson S, Kaddu-Mulindwa D, Kalyesubula I, Tumwine JK. Bacterial aetiology and outcome in children with severe pneumonia in Uganda. Ann Trop Paediatr. 2008 Dec;28(4):253–260. doi:10.1179/146532808X336405.
Recommended Articles
Research Article Open Access
Comparative Analgesic Efficacy of Intrathecal Fentanyl versus Intrathecal Midazolam as Adjuvants to Hyperbaric Bupivacaine for Elective Caesarean Section: A Randomized Double-Blinded Clinical Trial
2026, Volume-7, Issue 1 : 2477-2484
Research Article Open Access
Efficacy And Safety of Iv Lignocaine Versus Combination of Iv Lignocaine with Dexmedetomidine on Post Operative Pain and Functional Recovery After Laparoscopic Cholecystectomy, A Randomized Controlled Trial
2026, Volume-7, Issue 1 : 2522-2528
Research Article Open Access
Association Between Body Mass Index and Blood Pressure Variability Among Young Adults: A Cross-Sectional Study
2026, Volume-7, Issue 1 : 2501-2506
Research Article Open Access
Effect of a Structured Near-Peer Teaching Program on Clinical Skills Performance and Confidence Among MBBS Third-Year Students: A Comparative study
2026, Volume-7, Issue 1 : 2471-2476
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 1
Citations
4 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved